Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Change in Accured Expenses (2021 - 2026)

Alvotech's (ALVO) quarterly Change in Accured Expenses came in at $3.6 million in Q2 2026, down 57.42% on a YoY basis from $8.5 million in Q2 2025, and up 220.01% quarter-over-quarter from -$3.0 million in Q1 2026.

Analysis

Alvotech (ALVO) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Change in Accured Expenses for 6 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Accured Expenses fell 57.42% year-over-year to $3.6 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (up 106.21% YoY), and the FY2025 full-year result was -$2.2 million, up 71.63% from the prior year.
  • Change in Accured Expenses climbed to $3.6 million in Q2 2026 per ALVO's latest filing, from -$3.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $16.5 million in Q4 2025 and bottomed at -$25.0 million in Q3 2024.
  • Historically, Change in Accured Expenses has averaged -$1.0 million across 5 years, with a median of $815500.0 in 2022.
  • The widest YoY moves for Change in Accured Expenses: up 353.93% in 2024, down 722.21% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $493000.0 in 2022, then jumped by 156.59% to $1.3 million in 2023, then plunged by 722.21% to -$7.9 million in 2024, then surged by 309.48% to $16.5 million in 2025, then tumbled by 78.07% to $3.6 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $3.6 million, -$3.0 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 82.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -111.90 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 66.66 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 73.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 3.62 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 1.96 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Mn
Mar 31, 2026 -3.01 Mn
Dec 31, 2025 16.49 Mn
Sep 30, 2025 -14.80 Mn
Jun 30, 2025 8.49 Mn
Mar 31, 2025 -12.41 Mn
Dec 31, 2024 -7.87 Mn
Sep 30, 2024 -25.04 Mn
Jun 30, 2024 2.14 Mn
Mar 31, 2024 14.54 Mn
Dec 31, 2023 1.27 Mn
Jun 30, 2023 471,000.00
Dec 31, 2022 493,000.00
Jun 30, 2022 1.14 Mn
Dec 31, 2021 -1.16 Mn
Sep 30, 2021 -325,000.00